Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,159.00    20.00 (1.76%)
Bid:
1,159.00
Ask:
1,159.50
Spread: 0.50 (0.043%)
Market Cap: £9.84b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

8 Mar 2019 13:27

RNS Number : 3488S
Smith & Nephew Plc
08 March 2019
 

 

 

SMITH & NEPHEW PLC

 

 

8 March 2019

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

On 7 March 2019 the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") were granted under the Smith & Nephew Global Share Plan 2010. The Awards have been made in London and are based on the closing Share price on the London Stock Exchange on 6 March 2019 of £14.625.

 

1. PERFORMANCE SHARE AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2010

 

There are performance conditions attached to the vesting of performance share awards. These awards will vest on 7 March 2022, subject to the achievement of the performance conditions which are measured from 1 January 2019 to 31 December 2021. The number of shares subject to the above awards are shown at target vesting. Should maximum vesting be achieved, participants will receive 2x the number of shares shown below. Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

 

The following relates to all individuals included in this notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc Ordinary Shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Performance Share Awards granted at target on 7 March 2019 under the Smith & Nephew Global Share Plan 2010.

Date of Transaction

2019 - 03 - 07

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

Position / Status

Price (s)

Volume(s)

Aggregated information

Graham Baker

Chief Financial Officer

£14.625

35,480

N/A Single Transaction

Bradley Cannon

PDMR

£14.625

15,392

N/A Single Transaction

Massimiliano Colella

PDMR

£14.625

15,374

N/A Single Transaction

Phil Cowdy

PDMR

£14.625

11,282

N/A Single Transaction

Simon Fraser

PDMR

£14.625

13,583

N/A Single Transaction

Mark Gladwell

PDMR

£14.625

13,162

N/A Single Transaction

Melissa Guerdan

PDMR

£14.625

12,582

N/A Single Transaction

Skip Kiil

PDMR

£14.625

19,445

N/A Single Transaction

Elga Lohler

PDMR

£14.625

13,361

N/A Single Transaction

Namal Nawana

Chief Executive Officer

£14.625

76,065

N/A Single Transaction

Cathy O'Rourke

PDMR

£14.625

12,990

N/A Single Transaction

Vasant Padmanabhan

PDMR

£14.625

13,191

N/A Single Transaction

Susan Swabey

PDMR

£14.625

4,892

N/A Single Transaction

 

 

 

2. EQUITY INCENTIVE AWARDS GRANTED UNDER THE SMITH & NEPHEW GLOBAL SHARE PLAN 2010

 

The awards will normally vest in equal annual tranches over three years following the award date subject to continued achievement of objectives and employment. In the event that objectives are not met in any of the three years, the portion of shares due to vest on the following anniversary will lapse. Participants will receive an additional number of shares equivalent to the amount of dividend payable per vested share during the relevant performance period.

The following relates to all individuals included in this notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc Ordinary Shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Equity Incentive Awards granted on 7 March 2019 under the Smith & Nephew Global Share Plan 2010.

Date of Transaction

2019 - 03 - 07

Place of Transaction

London Stock Exchange (XLON)

 

Name

Position / Status

Price (s)

Volume(s)

Aggregated information

Graham Baker

Chief Financial Officer

£14.625

18,142

N/A Single Transaction

Bradley Cannon

PDMR

£14.625

13,984

N/A Single Transaction

Massimiliano Colella

PDMR

£14.625

13,976

N/A Single Transaction

Phil Cowdy

PDMR

£14.625

6,975

N/A Single Transaction

Mark Gladwell

PDMR

£14.625

6,526

N/A Single Transaction

Melissa Guerdan

PDMR

£14.625

5,547

N/A Single Transaction

Skip Kiil

PDMR

£14.625

17,677

N/A Single Transaction

Elga Lohler

PDMR

£14.625

13,259

N/A Single Transaction

Namal Nawana

Chief Executive Officer

£14.625

28,712

N/A Single Transaction

Cathy O'Rourke

PDMR

£14.625

12,868

N/A Single Transaction

Vasant Padmanabhan

PDMR

£14.625

11,992

N/A Single Transaction

Susan Swabey

PDMR

£14.625

4,892

N/A Single Transaction

 

 

Susan Swabey

Company Secretary

Smith & Nephew plc

 

Tel: 01923 477216

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFFVVEITIIA
Date   Source Headline
5th Jun 202612:12 pmRNSTransaction in Own Shares
4th Jun 20264:05 pmRNSDirector/PDMR Shareholding
3rd Jun 202611:21 amRNSDirector/PDMR Shareholding
3rd Jun 202610:35 amRNSAdmission to Trading
1st Jun 20263:10 pmRNSTotal Voting Rights
29th May 202610:37 amRNSTransaction in Own Shares
27th May 20269:31 amRNSPre Stabilisation Notice
22nd May 20261:32 pmRNSAdmission to Trading
22nd May 20269:58 amRNSTransaction in Own Shares
20th May 202611:25 amRNSDirector/PDMR Shareholding
19th May 20268:53 amRNSHolding(s) in Company
15th May 202612:28 pmRNSTransaction in Own Shares Replacement
15th May 202611:41 amRNSTransaction in Own Shares
14th May 20269:25 amRNSHolding(s) in Company
12th May 20264:03 pmRNSSterling Amount of Dividend
8th May 20267:00 amRNSShare Buyback Programme
6th May 20262:25 pmRNSResult of AGM
6th May 20267:00 amRNSSmith+Nephew First Quarter 2026 Trading Update
1st May 20261:10 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSExpert surgeons insights event for investors
22nd Apr 20268:46 amRNSNotice of Results
16th Apr 202611:12 amRNSDirector/PDMR Shareholding
15th Apr 20263:46 pmRNSDirector Declaration
14th Apr 20262:59 pmRNSReplacement: Annual Financial Report & AGM Notice
1st Apr 202612:23 pmRNSTotal Voting Rights
24th Mar 20264:16 pmRNSDirector/PDMR Shareholding
24th Mar 20268:45 amRNSHolding(s) in Company
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
16th Mar 20263:08 pmRNSAnnual Financial Report & Notice of AGM
10th Mar 20262:30 pmRNS-RSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
5th Mar 20267:30 amRNSDirector Declaration
2nd Mar 20261:36 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSFinal Results
5th Feb 202611:56 amRNSNotice of Results
2nd Feb 20264:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Feb 20263:05 pmRNSTotal Voting Rights
23rd Jan 20262:00 pmRNSDirector/PDMR Shareholding
21st Jan 20264:11 pmRNSCompletion of Acquisition
12th Jan 20264:30 pmRNSAcquisition of Integrity Orthopaedics
2nd Jan 202610:07 amRNSTotal Voting Rights
8th Dec 20257:00 amRNSNew Strategy and 2028 Financial Targets
1st Dec 20254:10 pmRNSTotal Voting Rights
19th Nov 202510:00 amRNSDirector/PDMR Shareholding
18th Nov 202510:18 amRNSHolding(s) in Company
12th Nov 20259:24 amRNSDirector/PDMR Shareholding
11th Nov 20254:40 pmRNSHolding(s) in Company
10th Nov 20251:46 pmRNSDirector/PDMR Shareholding
7th Nov 20259:38 amRNSDirector/PDMR Shareholding
7th Nov 20259:35 amRNSDirector/PDMR Shareholding
6th Nov 20257:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.